Search

everythinglearnresearchcommunity

for

Search:↓

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

Oral minoxidil shows promise in treating monilethrix-related hair loss.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

Early diagnosis and effective treatment of kerion Celsi prevent scarring and permanent hair loss.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Genetic factors alone might not cause pemphigus vulgaris; other factors like birth complications and puberty may trigger it.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Different treatments for alopecia areata have unpredictable results and varying success rates.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

A 1-day or 3-day itraconazole treatment is effective for acute vulvovaginal candidosis, but recurrent cases may need longer treatment.

The document concludes that syphilis has varied symptoms that are often missed, making clinical awareness crucial for diagnosis.

Blocking interferon-gamma might help treat various autoimmune diseases.

Using a nonablative fractional laser with topical minoxidil can effectively and safely promote hair regrowth in alopecia areata patients.

The study found that polymorphous light eruption varies among patients and can be distinguished from benign summer light eruption by the time it takes for symptoms to appear after sun exposure.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

A cat with hair loss and illness was found to have cancer spread from its colon.

Platelet-rich plasma (PRP) is effective in treating various skin conditions and improving hair density, thickness, and patient satisfaction, with lower relapse rates for Alopecia Areata.